Pharmacoproteomics in Cardiac Hypertrophy and Atherosclerosis

E-ISSN： 2212-4063|9|2|141-148

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.9, Iss.2, 2009-06, pp. : 141-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pleiotropic Effect of Statins as Antioxidants on Cardiac Hypertrophy

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 8, Iss. 2, 2008-06 ,pp. : 167-171

Bentham Science Publishers

Access to resources Recommend Favorite

Meloxicam Prevents Load-Induced Cardiac Hypertrophy in Mice

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 143-146

Bentham Science Publishers

Access to resources Recommend Favorite

The First Line of Defense Against Cardiac Hypertrophy

Current Molecular Medicine, Vol. 13, Iss. 4, 2013-05 ,pp. : 670-680

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA Regulation and Role in Stem Cell Maintenance, Cardiac Differentiation and Hypertrophy

Current Molecular Medicine, Vol. 13, Iss. 5, 2013-01 ,pp. : 757-764

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of donor age in graft coronary atherosclerosis after cardiac transplantation

By Kobayashi Y. Fukushima N. Ohtake S. Sawa Y. Nishimura M. Matsumiya G. Horiguchi K. Matsuda H.

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2587-2588

Elsevier

Access to resources Recommend Favorite